ANDA 76448, held by Barr. Topiramate.
As of Nov 15, 2026, ANDA 76448 (Topiramate), held by Barr, was first approved by FDA on Dec 17, 2003, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 17, 2003 | Original application | Approved |
| Topiramate15MG · capsule;oral | Topiramate | Discontinued |
| Topiramate25MG · capsule;oral | Topiramate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters